Abstract
Sleep is homeostatically regulated in all species that have been carefully studied. In mammals and birds, the best characterized marker of sleep pressure is slow wave activity (SWA), defined as the electroencephalogram (EEG) power between 0.5 and 4 Hz during NREM sleep. SWA peaks at sleep onset and decreases with time spent asleep, and reflects the synchronous firing of cortical neurons coordinated by an underlying slow oscillation, the fundamental cellular phenomenon of NREM sleep. We have recently proposed the synaptic homeostasis hypothesis of sleep, which claims that an important function of sleep is to maintain synaptic balance. This hypothesis states that plastic processes during wake are biased towards synaptic potentiation, resulting in a net increase in synaptic strength in many brain circuits. Such increased synaptic weight would be unsustainable in the long run, due to increased demand for energy, space and supplies, and risk of synaptic saturation. Thus, according to the synaptic homeostasis hypothesis, sleep is important to renormalize synaptic strength to a baseline level that is sustainable and beneficial for memory and performance. There is strong evidence that the amplitude and slope of EEG slow waves is related to the number of neurons that enter an up state or a down state of the slow oscillation near-synchronously, and that synchrony is directly related to the number, strength, and efficacy of synaptic connections among them. Thus, the average synaptic strength (number or efficacy of synapses) reached in a given cortical area at the end of the major wake phase should be reflected by the level of SWA in the EEG at sleep onset. Moreover, according to the hypothesis, sleep SWA is not only a useful proxy of wake-related cortical synaptic strength, but could mediate the renormalization of neural circuits by favoring net synaptic depression, perhaps aided by low levels of norepinephrine, serotonin, and acetylcholine during NREM sleep. Here we briefly review human and animal studies showing that, consistent with this hypothesis, 1) in the adult cerebral cortex wake is associated with a net increase in synaptic strength, and sleep with a net decrease; and 2) SWA reflects not just prior “use” of specific neuronal circuits, but rather the occurrence of plastic changes, with increases in SWA after synaptic potentiation, and decreases in SWA after synaptic depression. We end by discussing current challenges to this hypothesis and future research directions.
Keywords: Sleep homeostasis, local sleep, slow wave activity, EEG, plasticity, Synaptic homeostasis, cortical neurons, slow oscillation, brain circuits, synaptic homeostasis hypothesis, synaptic potentiation, fundamental cellular phenomenon, homeostatic behavio, neuronal synchronization, Behavioral manipulations
Current Topics in Medicinal Chemistry
Title: Synaptic Potentiation and Sleep Need: Clues from Molecular and Electrophysiological Studies
Volume: 11 Issue: 19
Author(s): Erin C. Hanlon, Vladyslav V. Vyazovskiy, Ugo Faraguna, Giulio Tononi and Chiara Cirelli
Affiliation:
Keywords: Sleep homeostasis, local sleep, slow wave activity, EEG, plasticity, Synaptic homeostasis, cortical neurons, slow oscillation, brain circuits, synaptic homeostasis hypothesis, synaptic potentiation, fundamental cellular phenomenon, homeostatic behavio, neuronal synchronization, Behavioral manipulations
Abstract: Sleep is homeostatically regulated in all species that have been carefully studied. In mammals and birds, the best characterized marker of sleep pressure is slow wave activity (SWA), defined as the electroencephalogram (EEG) power between 0.5 and 4 Hz during NREM sleep. SWA peaks at sleep onset and decreases with time spent asleep, and reflects the synchronous firing of cortical neurons coordinated by an underlying slow oscillation, the fundamental cellular phenomenon of NREM sleep. We have recently proposed the synaptic homeostasis hypothesis of sleep, which claims that an important function of sleep is to maintain synaptic balance. This hypothesis states that plastic processes during wake are biased towards synaptic potentiation, resulting in a net increase in synaptic strength in many brain circuits. Such increased synaptic weight would be unsustainable in the long run, due to increased demand for energy, space and supplies, and risk of synaptic saturation. Thus, according to the synaptic homeostasis hypothesis, sleep is important to renormalize synaptic strength to a baseline level that is sustainable and beneficial for memory and performance. There is strong evidence that the amplitude and slope of EEG slow waves is related to the number of neurons that enter an up state or a down state of the slow oscillation near-synchronously, and that synchrony is directly related to the number, strength, and efficacy of synaptic connections among them. Thus, the average synaptic strength (number or efficacy of synapses) reached in a given cortical area at the end of the major wake phase should be reflected by the level of SWA in the EEG at sleep onset. Moreover, according to the hypothesis, sleep SWA is not only a useful proxy of wake-related cortical synaptic strength, but could mediate the renormalization of neural circuits by favoring net synaptic depression, perhaps aided by low levels of norepinephrine, serotonin, and acetylcholine during NREM sleep. Here we briefly review human and animal studies showing that, consistent with this hypothesis, 1) in the adult cerebral cortex wake is associated with a net increase in synaptic strength, and sleep with a net decrease; and 2) SWA reflects not just prior “use” of specific neuronal circuits, but rather the occurrence of plastic changes, with increases in SWA after synaptic potentiation, and decreases in SWA after synaptic depression. We end by discussing current challenges to this hypothesis and future research directions.
Export Options
About this article
Cite this article as:
C. Hanlon Erin, V. Vyazovskiy Vladyslav, Faraguna Ugo, Tononi Giulio and Cirelli Chiara, Synaptic Potentiation and Sleep Need: Clues from Molecular and Electrophysiological Studies, Current Topics in Medicinal Chemistry 2011; 11 (19) . https://dx.doi.org/10.2174/156802611797470312
DOI https://dx.doi.org/10.2174/156802611797470312 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Comparative Study of the Effects Exerted by N-Valproyl-L-Phenylalanine and N-valproyl-L-tryptophan on CA1 Hippocampal Epileptiform Activity in Rat
Current Pharmaceutical Design Structure-Activity Studies on Alpha-Conotoxins
Current Pharmaceutical Design Novel Methods of Genetic Modification of Human Pluripotent Stem Cells
Recent Patents on Regenerative Medicine Targeting Potassium Channels: New Advances in Cardiovascular Therapy
Recent Patents on Cardiovascular Drug Discovery Psychopharmacologic Treatment of Children and Adolescents with Bipolar Disorder: A Review
Adolescent Psychiatry Using Literature-based Discovery to Identify Novel Therapeutic Approaches
Cardiovascular & Hematological Agents in Medicinal Chemistry Gene Therapy, A Novel Therapeutic Tool for Neurological Disorders: Current Progress, Challenges and Future Prospective
Current Gene Therapy Extracellular Level of GABA and Glu: In Vivo Microdialysis-HPLC Measurements
Current Topics in Medicinal Chemistry MicroRNA Therapeutics in Neurological Disease
Current Pharmaceutical Design Synthesis and Anticonvulsant Activity of 7-Alkoxy-Triazolo-[3, 4-b] Benzo[d]Thiazoles
Medicinal Chemistry Editorial [Hot topic:VIP and PACAP: Novel Approaches to Brain Functions and Neuroprotection (Executive Guest Editors: Seiji Shioda and Illana Gozes)]
Current Pharmaceutical Design Antiepileptic Treatment Strategy in Vascular Malformations
Current Pharmaceutical Design Potential Mechanisms Involved in the Anticonvulsant Effect of Methanol Extract of <i>Pyrenancantha staudtii</i> in Mice
Central Nervous System Agents in Medicinal Chemistry Psychomotor Seizure Test, Neurotoxicity and in vitro Neuroprotection Assay of some Semicarbazone Analogues
Central Nervous System Agents in Medicinal Chemistry Melatonin-mitochondria Interplay in Health and Disease
Current Topics in Medicinal Chemistry The Endocannabinoid System and Pain
CNS & Neurological Disorders - Drug Targets Preventive and Therapeutic Effects of the Retinoid X Receptor Agonist Bexarotene on Tumors
Current Drug Metabolism Antiepileptic Drugs in Clinical Development: Differentiate or Die?
Current Pharmaceutical Design Role of Kynurenines in the Central and Peripherial Nervous Systems
Current Neurovascular Research Novel Directions in Antipsychotic Target Identification using Gene Arrays
Current Drug Targets - CNS & Neurological Disorders